Practical asymmetric synthesis of Efavirenz (DMP 266), an HIV-1 reverse transcriptase inhibitor

Michael E. Pierce, Rodney L. Parsons, Lilian A. Radesca, Young S. Lo, Stuart Silverman, James R. Moore, Qamrul Islam, Anusuya Choudhury, Joseph M.D. Fortunak, Dieu Nguyen, Chi Luo, Susan J. Morgan, Wayne P. Davis, Pat N. Confalone, Cheng Yi Chen, Richard D. Tillyer, Lisa Frey, Lushi Tan, Feng Xu, Dalian ZhaoAndrew S. Thompson, Edward G. Corley, Edward J.J. Grabowski, Robert Reamer, Paul J. Reider

Research output: Contribution to journal › Article › peer-review

220 Scopus citations

Fingerprint

Dive into the research topics of 'Practical asymmetric synthesis of Efavirenz (DMP 266), an HIV-1 reverse transcriptase inhibitor'. Together they form a unique fingerprint.

Chemical Compounds